JPH0480007B2 - - Google Patents

Info

Publication number
JPH0480007B2
JPH0480007B2 JP23776487A JP23776487A JPH0480007B2 JP H0480007 B2 JPH0480007 B2 JP H0480007B2 JP 23776487 A JP23776487 A JP 23776487A JP 23776487 A JP23776487 A JP 23776487A JP H0480007 B2 JPH0480007 B2 JP H0480007B2
Authority
JP
Japan
Prior art keywords
soysterol
pantethine
present
group
hyperlipidemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP23776487A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6479119A (en
Inventor
Yoshiaki Nakai
Munehiro Tomikawa
Naoki Imoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP23776487A priority Critical patent/JPS6479119A/ja
Publication of JPS6479119A publication Critical patent/JPS6479119A/ja
Publication of JPH0480007B2 publication Critical patent/JPH0480007B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP23776487A 1987-09-22 1987-09-22 Drug of blended two components Granted JPS6479119A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23776487A JPS6479119A (en) 1987-09-22 1987-09-22 Drug of blended two components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23776487A JPS6479119A (en) 1987-09-22 1987-09-22 Drug of blended two components

Publications (2)

Publication Number Publication Date
JPS6479119A JPS6479119A (en) 1989-03-24
JPH0480007B2 true JPH0480007B2 (enExample) 1992-12-17

Family

ID=17020100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23776487A Granted JPS6479119A (en) 1987-09-22 1987-09-22 Drug of blended two components

Country Status (1)

Country Link
JP (1) JPS6479119A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010033A1 (en) * 1994-09-29 1996-04-04 The University Of British Columbia Sterol compositions from pulping soap
ES2345713T3 (es) * 2002-09-30 2010-09-30 Daiichi Pharmaceutical Co., Ltd. Producto particulado que contiene pantetina.
JP2006016356A (ja) * 2004-07-02 2006-01-19 Dai Ichi Seiyaku Co Ltd 高コレステロール症用組成物

Also Published As

Publication number Publication date
JPS6479119A (en) 1989-03-24

Similar Documents

Publication Publication Date Title
US5173304A (en) Agents for the treatment of severe pain and preparation of said agents
NL193340C (nl) Farmaceutisch preparaat voor parenterale toediening gevormd uit een vetemulsie.
JPH06501695A (ja) 主要血管事象を抑制するためのベータ−カロテン及びビタミンｅ療法
US11839590B2 (en) Flurbiprofen axetil emulsion for injection and preparation method thereof
US20110053903A1 (en) Pharmaceutical compositions based on azetidine derivatives
JP2002518440A (ja) β−ヒドロキシ−β−メチル酪酸および少なくとも１つのアミノ酸を含む組成物および使用法
KR100272483B1 (ko) 지질 대사 개선제
HUP0700038A2 (en) Use of (3r,4r)-delta8-tetrahydrocannabinol-11-oic acids for the preparation of medicines for decreasing cell proliferation
EP0759294B1 (en) Hypercholesterolemia therapeutic agent
RO115782B1 (ro) Compozitie farmaceutica
AU2002364866B2 (en) Pharmaceutical compositions based on azetidine derivatives
Rasker et al. Lack of beneficial effect of zinc sulphate in rheumatoid arthritis
JP2024175025A (ja) 組織の灌流の増加における使用のためのイノシトールリン酸化合物
EP0891771A1 (en) Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases
JP2004002429A (ja) 組成物およびその治療用途
JP2002249431A (ja) トリグリセリド低下剤組成物
JP2003516348A (ja) がん治療のための細胞増殖抑制剤及び電子受容体を含有する医薬製剤
JPH0480007B2 (enExample)
US4472436A (en) Increasing HDL-cholesterol levels with phenylethylamine derivatives
AU2018352039A1 (en) Cannabidiol and chitosan compositions and methods of using the same
JP4824573B2 (ja) 腎不全、腎疾患または腎障害、特に糖尿病患者におけるこれらの治療のための医薬組成物
ES2236487T3 (es) Formulacion farmaceutica y su uso para preparar un medicamento para el tratamiento de enfermedades cardiovasculares.
JPH08208464A (ja) 高脂血症の治療及び予防薬
AU611204B2 (en) Treatment of lipoprotein disorders associated with cholesterol metabolism
JP2000256196A (ja) 抗炎症，抗アレルギー剤

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071217

Year of fee payment: 15